Liver Interventions in Children

Abstract

This review provides a comprehensive summary of the role of the interventional radiologist in managing liver disorders in children. Interventions are discussed with focus on indications for procedure, technical aspects, and patient management. Recommendations are supported by the most recent evidence and practice experience of the authors in the four subtopics, such as interventions in the post–liver transplant setting, for portal hypertension, for liver tumors, and for vascular anomalies of the liver, with emphasis on congenital portosystemic shunts.

Keywords

pediatric liver transplant - pediatric portal hypertension - pediatric liver tumor intervention - congenital portosystemic shunts

Publication History

Received: 31 March 2023

Accepted: 20 June 2023

Article published online:
31 July 2023

• References

• 1 Rawal N, Yazigi N. Pediatric liver transplantation. Pediatr Clin North Am 2017; 64 (03) 677-684
• 2 Horvat N, Marcelino ASZ, Horvat JV. et al. Pediatric liver transplant: techniques and complications. Radiographics 2017; 37 (06) 1612-1631
• 3 Moussaoui D, Toso C, Nowacka A. et al. Early complications after liver transplantation in children and adults: Are split grafts equal to each other and equal to whole livers?. Pediatr Transplant 2017; 21 (04)
• 4 Monroe EJ, Shivaram GM. Pediatric hepatobiliary interventions in the setting of intrahepatic vascular malformations, portal hypertension, and liver transplant. Semin Roentgenol 2019; 54 (04) 311-323
• 5 Franchi-Abella S, Cahill AM, Barnacle AM, Pariente D, Roebuck DJ. Hepatobiliary intervention in children. Cardiovasc Intervent Radiol 2014; 37 (01) 37-54
• 6 Sanada Y, Katano T, Hirata Y. et al. Interventional radiology treatment for vascular and biliary complications following pediatric living donor liver transplantation - a retrospective study. Transpl Int 2018; 31 (11) 1216-1222
• 7 Seda-Neto J, Antunes da Fonseca E, Pugliese R. et al. Twenty years of experience in pediatric living donor liver transplantation: focus on hepatic artery reconstruction, complications, and outcomes. Transplantation 2016; 100 (05) 1066-1072
• 8 Channaoui A, Tambucci R, Pire A. et al. Management and outcome of hepatic artery thrombosis after pediatric liver transplantation. Pediatr Transplant 2021; 25 (05) e13938
• 9 Cuenca AG, Kim HB, Vakili K. Pediatric liver transplantation. Semin Pediatr Surg 2017; 26 (04) 217-223
• 10 Tarango C, Manco-Johnson MJ. Pediatric thrombolysis: a practical approach. Front Pediatr 2017; 5 (December): 260
• 11 Pereira K, Salsamendi J, Dalal R, Quintana D, Bhatia S, Fan J. Percutaneous endovascular therapeutic options in treating posttransplant hepatic artery thrombosis with the aim of salvaging liver allografts: our experience. Exp Clin Transplant 2016; 14 (05) 542-550
• 12 Maruzzelli L, Miraglia R, Caruso S. et al. Percutaneous endovascular treatment of hepatic artery stenosis in adult and pediatric patients after liver transplantation. Cardiovasc Intervent Radiol 2010; 33 (06) 1111-1119
• 13 Parra DA, Brandao L. Use of drug-coated balloons in the management of a recalcitrant postsurgical hepatic vein stenosis in a pediatric patient. Radiol Case Rep 2020; 15 (10) 1864-1869
• 14 Monroe EJ, Speir EJ, Hawkins CM, Shivaram G, Koo KSH, Gill AE. Transsplenic splenoportography and portal venous interventions in pediatric patients. Pediatr Radiol 2018; 48 (10) 1441-1450
• 15 Shibata T, Itoh K, Kubo T. et al. Percutaneous transhepatic balloon dilation of portal venous stenosis in patients with living donor liver transplantation. Radiology 2005; 235 (03) 1078-1083
• 16 Camacho JC, Coursey-Moreno C, Telleria JC, Aguirre DA, Torres WE, Mittal PK. Nonvascular post-liver transplantation complications: from US screening to cross-sectional and interventional imaging. Radiographics 2015; 35 (01) 87-104
• 17 Dopazo C, Diez I, Quintero J. et al. Role of biodegradable stents as part of treatment of biliary strictures after pediatric and adult liver transplantation: an observational single-center study. J Vasc Interv Radiol 2018; 29 (06) 899-904
• 18 Reis SP, Bruestle K, Brejt S. et al. Evaluation of a three-session biliary dilation protocol following transplant-related biliary stricture in pediatric patients. Pediatr Transplant 2019; 23 (07) e13551
• 19 D'Antiga L. Medical management of esophageal varices and portal hypertension in children. Semin Pediatr Surg 2012; 21 (03) 211-218
• 20 Luoto TT, Koivusalo AI, Pakarinen MP. Long-term outcomes and health perceptions in pediatric-onset portal hypertension complicated by varices. J Pediatr Gastroenterol Nutr 2020; 70 (05) 628-634
• 21 Grammatikopoulos T, McKiernan PJ, Dhawan A. Portal hypertension and its management in children. Arch Dis Child 2018; 103 (02) 186-191
• 22 Ling SC, Ch MBB. Portal hypertension in children. Clin Liver Dis (Hoboken) 2012; 1 (05) 139-142
• 23 Lv Y, He C, Guo W. et al. Transjugular intrahepatic portosystemic shunt for extrahepatic portal venous obstruction in children. J Pediatr Gastroenterol Nutr 2016; 62 (02) 233-241
• 24 de Franchis R, Abraldes JG, Bajaj J. et al; Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63 (03) 743-752
• 25 Zhang YQ, Wang Q, Wu M. et al. Optimal Rex shunt procedures as a treatment for pediatric extrahepatic portal hypertension. Pediatr Surg Int 2021; 37 (05) 597-606
• 26 Duché M, Ducot B, Ackermann O, Guérin F, Jacquemin E, Bernard O. Portal hypertension in children: high-risk varices, primary prophylaxis and consequences of bleeding. J Hepatol 2017; 66 (02) 320-327
• 27 Stein EJ, Shivaram GM, Koo KSH, Dick AAS, Healey PJ, Monroe EJ. Endovascular treatment of surgical mesoportal and portosystemic shunt dysfunction in pediatric patients. Pediatr Radiol 2019; 49 (10) 1344-1353
• 28 Young V, Rajeswaran S. Management of portal hypertension in the pediatric population: a primer for the interventional radiologist. Semin Intervent Radiol 2018; 35 (03) 160-164
• 29 Shukla A, Shreshtha A, Mukund A. et al. Budd-Chiari Syndrome: Consensus Guidance of the Asian Pacific Association for the Study of the Liver (APASL). Vol 15. India: Springer; 2021. doi:
• 30 Sharma VK, Ranade PR, Marar S, Nabi F, Nagral A. Long-term clinical outcome of Budd-Chiari syndrome in children after radiological intervention. Eur J Gastroenterol Hepatol 2016; 28 (05) 567-575
• 31 Deshmukh A, Jhaveri A, Nagral A, Marar S. Techniques and outcomes of transjugular intrahepatic portosystemic shunting in infants with Budd-Chiari syndrome. J Vasc Interv Radiol 2021; 32 (12) 1637-1643
• 32 Singh SK, Sen Sarma M, Yadav R. et al. Prognostic scoring systems and outcome of endovascular radiological intervention of chronic Budd-Chiari syndrome in children. Liver Int 2018; 38 (07) 1308-1315
• 33 Sutton H, Dhawan A, Grammatikopoulos T. Non-invasive markers of portal hypertension: appraisal of adult experience and potential utilisation in children. J Pediatr Gastroenterol Nutr 2018; 66 (04) 559-569
• 34 Konuş ÖL, Özdemir A, Akkaya A, Erbaş G, Çelik H, Işik S. Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography. AJR Am J Roentgenol 1998; 171 (06) 1693-1698
• 35 Kim DW, Yoon HM, Jung AY. et al. Diagnostic performance of ultrasound elastography for evaluating portal hypertension in children: a systematic review and meta-analysis. J Ultrasound Med 2019; 38 (03) 747-759
• 36 Smith TP, Kim CY, Smith AD. et al. Hepatic venous pressure measurements: comparison of end-hole and balloon catheter methods. J Vasc Interv Radiol 2012; 23 (02) 219-26.e6
• 37 Srivastava A, Prasad D, Panda I. et al. Transjugular versus percutaneous liver biopsy in children: indication, success, yield, and complications. J Pediatr Gastroenterol Nutr 2020; 70 (04) 417-422
• 38 Lal BB, Sood V, Rastogi A. et al. Safety, feasibility, yield, diagnostic and prognostic implications of transjugular liver biopsy in children and adolescents. J Pediatr Gastroenterol Nutr 2021; 73 (05) e109-e114
• 39 Tulin-Silver S, Obi C, Kothary N, Lungren MP. Comparison of transjugular liver biopsy and percutaneous liver biopsy with tract embolization in pediatric patients. J Pediatr Gastroenterol Nutr 2018; 67 (02) 180-184
• 40 Ebel NH, Carlin K, Shaffer ML. et al. Hepatic venous pressure gradient measurements in children: correlation with hepatic histology and clinical indicators of portal hypertension. J Pediatr Gastroenterol Nutr 2019; 68 (06) 788-792
• 41 Monroe EJ, Michalsky WS, Koo KSH. et al. Intrahepatic veno-venous collateralization and misrepresentative hepatic venous pressure gradients in children. Pediatr Radiol 2020; 50 (11) 1579-1586
• 42 McKiernan PJ. Treatment of variceal bleeding. Gastrointest Endosc Clin N Am 2001; 11 (04) 789-812, viii
• 43 Pai AK, Jonas MM, Fox VL. Esophageal capsule endoscopy in children and young adults with portal hypertension. J Pediatr Gastroenterol Nutr 2019; 69 (06) 641-647
• 44 Cifuentes L, Gattini D, Torres-Robles R, Gana JC. Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis (Review). Cochrane Database Syst Rev 2021; 1 (01) CD011973
• 45 Di Giorgio A, Nicastro E, Agazzi R, Colusso M, D'Antiga L. Long-term outcome of transjugular intrahepatic portosystemic shunt in children with portal hypertension. J Pediatr Gastroenterol Nutr 2020; 70 (05) 615-622
• 46 Regnault D, d'Alteroche L, Nicolas C, Dujardin F, Ayoub J, Perarnau JM. Ten-year experience of transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension. Eur J Gastroenterol Hepatol 2018; 30 (05) 557-562
• 47 Lv Y, Yang Z, Liu L. et al; AVB-TIPS Study Group. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol 2019; 4 (08) 587-598
• 48 García-Pagán JC, Caca K, Bureau C. et al; Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362 (25) 2370-2379
• 49 Bertino F, Hawkins CM, Shivaram G. et al. Technical feasibility and clinical effectiveness of transjugular intrahepatic portosystemic shunt creation in pediatric and adolescent patients. J Vasc Interv Radiol 2019; 30 (02) 178-186.e5
• 50 Johansen LC, McKiernan PJ, Sharif K, McGuirk SP. Transjugular intrahepatic portosystemic shunt insertion for the management of portal hypertension in children. J Pediatr Gastroenterol Nutr 2018; 67 (02) 173-179
• 51 de Ville de Goyet J, D'Ambrosio G, Grimaldi C. Surgical management of portal hypertension in children. Semin Pediatr Surg 2012; 21 (03) 219-232
• 52 Lukies M, Moriarty H, Phan T. Modified gun-sight transjugular intrahepatic portosystemic shunt technique. Br J Radiol 2022; 95 (1140): 20220556
• 53 Slowik V, Monroe EJ, Friedman SD, Hsu EK, Horslen S. Pressure gradients, laboratory changes, and outcomes with transjugular intrahepatic portosystemic shunts in pediatric portal hypertension. Pediatr Transplant 2019; 23 (03) e13387
• 54 Perry BC, Monroe EJ, Shivaram G. Adjustable diameter TIPS in the pediatric patient: the constrained technique. Diagn Interv Radiol 2018; 24 (03) 166-168
• 55 Chlapoutaki CE, Franchi-Abella S, Habes D, Pariente D. Custom-made covered transjugular intrahepatic portosystemic shunt (TIPS) in an infant with trisomy 22 and biliary atresia. Pediatr Radiol 2009; 39 (07) 739-742
• 56 Lorenz JM. Placement of transjugular intrahepatic portosystemic shunts in children. Tech Vasc Interv Radiol 2008; 11 (04) 235-240
• 57 Weber CN, Nadolski GJ, White SB. et al. Long-term patency and clinical analysis of expanded polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunt stent grafts. J Vasc Interv Radiol 2015; 26 (09) 1257-1265 , quiz 1265
• 58 Vo NJ, Shivaram G, Andrews RT, Vaidya S, Healey PJ, Horslen SP. Midterm follow-up of transjugular intrahepatic portosystemic shunts using polytetrafluoroethylene endografts in children. J Vasc Interv Radiol 2012; 23 (07) 919-924
• 59 Ghannam JS, Cline MR, Hage AN. et al. Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience. Pediatr Radiol 2019; 49 (01) 128-135
• 60 Casadaban LC, Parvinian A, Minocha J. et al. Clearing the confusion over hepatic encephalopathy after TIPS creation: incidence, prognostic factors, and clinical outcomes. Dig Dis Sci 2015; 60 (04) 1059-1066
• 61 Deswal S, Madhusudhan KS, Sharma S, Malik R. Balloon-occluded retrograde transvenous obliteration (BRTO): a treatment option in children with gastric varices. Indian J Pediatr 2020; 87 (12) 1078-1079
• 62 Waguri N, Osaki A, Watanabe Y. Balloon-occluded retrograde transvenous obliteration for treatment of gastric varices. World J Hepatol 2021; 13 (06) 650-661
• 63 Sasaki T, Hasegawa T, Kimura T. et al. Balloon-occluded retrograde transvenous obliteration performed in a pediatric patient with isolated gastric fundal varices. J Pediatr Surg 2004; 39 (01) 130-132
• 64 Hisamatsu C, Kawasaki R, Yasufuku M, Maeda K. Efficacy and safety of balloon-occluded retrograde transvenous obliteration for gastric fundal varices in children. Pediatr Surg Int 2008; 24 (10) 1141-1144
• 65 Pimpalwar S, Chinnadurai P, Hernandez A, Kukreja K, Siddiqui S, Justino H. Trans-splenic access for portal venous interventions in children: Do benefits outweigh risks?. Cardiovasc Intervent Radiol 2018; 41 (01) 87-95
• 66 Giouleme O, Theocharidou E. Management of portal hypertension in children with portal vein thrombosis. J Pediatr Gastroenterol Nutr 2013; 57 (04) 419-425
• 67 Koo KSH, Lamar DL, Shaw DWW, Monroe EJ, Shivaram GM. Catheter-directed thrombolysis for portal vein thrombosis in children: a case series. J Vasc Interv Radiol 2018; 29 (11) 1578-1583
• 68 Cleveland H, Pimpalwar S, Ashton D, Chau A, Nagaraj A, Hernandez JA. Recanalization of chronic portal vein occlusion in pediatric liver transplant patients. J Vasc Interv Radiol 2019; 30 (06) 885-891
• 69 Muratore S, Flanagan S, Hunter D, Acton R. Recanalization of chronic extrahepatic portal vein obstruction in pediatric patients using a minilaparotomy approach. J Pediatr Gastroenterol Nutr 2019; 68 (03) 384-388
• 70 Parra JR, Bertino FJ, Shin DS, Chick JFB, Koo KSH, Monroe EJ. Portomesenteric and portosystemic venous reconstructions in children using balloon-expandable endoprostheses. Pediatr Radiol 2022; 52 (03) 493-500
• 71 Cwikiel W, Keussen I, Larsson L, Solvig J, Kullendorff CM. Interventional treatment of children with portal hypertension secondary to portal vein occlusion. Eur J Pediatr Surg 2003; 13 (05) 312-318
• 72 Wei B, Huang Z, Wu H. et al. Portal vein recanalization for noncirrhotic portal vein cavernous transformation: transjugular intrahepatic portosystemic shunt creation versus portal vein stent placement. J Vasc Interv Radiol 2023; 34 (02) 187-194
• 73 Li ZP, Wang SS, Wang GC, Huang GJ, Cao JQ, Zhang CQ. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein. Hepatobiliary Pancreat Dis Int 2018; 17 (06) 517-523
• 74 Valentin N, Korrapati P, Constantino J, Young A, Weisberg I. The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2018; 30 (10) 1187-1193
• 75 Saad WEA, Anderson CL, Patel RS. et al. Management of gastric varices in the pediatric population with balloon-occluded retrograde transvenous obliteration (BRTO) utilizing sodium tetradecyl sulfate foam sclerosis with or without partial splenic artery embolization. Cardiovasc Intervent Radiol 2015; 38 (01) 236-241
• 76 Vittorio J, Orellana K, Martinez M. et al. Partial splenic embolization is a safe and effective alternative in the management of portal hypertension in children. J Pediatr Gastroenterol Nutr 2019; 68 (06) 793-798
• 77 Ogawa S, Yamamoto A, Jogo A. et al. Splenic vein diameter is a risk factor for the portal venous system thrombosis after partial splenic artery embolization. Cardiovasc Intervent Radiol 2021; 44 (06) 921-930
• 78 Towbin AJ, Meyers RL, Woodley H. et al. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol 2018; 48 (04) 536-554
• 79 Weldon CB, Madenci AL, Tiao GM. et al. Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: a report from the Children's Oncology Group AHEP 0731 liver tumor committee. J Pediatr Surg 2020; 55 (04) 655-659
• 80 Shaikh R, Munoz FG. Endovascular approaches in pediatric interventional oncology. CVIR Endovasc 2021; 4 (01) 2
• 81 Hirakawa M, Nishie A, Asayama Y. et al. Efficacy of preoperative transcatheter arterial chemoembolization combined with systemic chemotherapy for treatment of unresectable hepatoblastoma in children. Jpn J Radiol 2014; 32 (09) 529-536
• 82 Tan X, Zhang J, Wen Z. et al. Preoperative transcatheter arterial chemoembolization of hepatoblastoma in infants. J Vasc Interv Radiol 2014; 25 (07) 1029-1035
• 83 Li JP, Chu JP, Yang JY, Chen W, Wang Y, Huang YH. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children. Cardiovasc Intervent Radiol 2008; 31 (06) 1117-1123
• 84 Weiss KE, Sze DY, Rangaswami AA. et al. Transarterial chemoembolization in children to treat unresectable hepatocellular carcinoma. Pediatr Transplant 2018; 22 (04) e13187
• 85 Aguado A, Ristagno R, Towbin AJ. et al. Transarterial radioembolization with yttrium-90 of unresectable primary hepatic malignancy in children. Pediatr Blood Cancer 2019; 66 (07) e27510
• 86 Hawkins CM, Kukreja K, Geller JI, Schatzman C, Ristagno R. Radioembolisation for treatment of pediatric hepatocellular carcinoma. Pediatr Radiol 2013; 43 (07) 876-881
• 87 Matthew Hawkins C, Towbin AJ, Roebuck DJ. et al. Role of interventional radiology in managing pediatric liver tumors: Part 2: Percutaneous interventions. Pediatr Radiol 2018; 48 (04) 565-580
• 88 Botsa E, Poulou LS, Koutsogiannis I. et al. CT-guided radiofrequency tumor ablation in children. Pediatr Radiol 2014; 44 (11) 1421-1425
• 89 Deodhar A, Brody LA, Covey AM, Brown KT, Getrajdman GI. Bland embolization in the treatment of hepatic adenomas: preliminary experience. J Vasc Interv Radiol 2011; 22 (06) 795-799 , quiz 800
• 90 McDaniel JD, Kukreja K, Ristagno RL, Yazigi N, Nathan JD, Tiao G. Radiofrequency ablation of a large hepatic adenoma in a child. J Pediatr Surg 2013; 48 (06) E19-E22
• 91 Warmann S, Bertram H, Kardorff R, Sasse M, Hausdorf G, Fuchs J. Interventional treatment of infantile hepatic hemangioendothelioma. J Pediatr Surg 2003; 38 (08) 1177-1181
• 92 Whiting Jr JH, Korzenik JR, Miller Jr FJ, Pollack JS, White Jr RI. Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Radiol 2000; 11 (07) 855-858
• 93 Buscarini E, Buscarini L, Danesino C. et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. J Hepatol 1997; 26 (01) 111-118
• 94 Le Corre F, Golkar B, Tessier C, Kavafyan J, Marty J. Liver transplantation for hepatic arteriovenous malformation with high-output cardiac failure in hereditary hemorrhagic telangiectasia: hemodynamic study. J Clin Anesth 2000; 12 (04) 339-342
• 95 Burrows PE, Dubois J, Kassarjian A, Burrows PE, Kassarjian A, Dubois J. Pediatric hepatic vascular anomalies. Pediatr Radiol 2001; 31 (08) 533-545
• 96 Boon LM, Burrows PE, Paltiel HJ. et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996; 129 (03) 346-354
• 97 Alexander CP, Sood BG, Zilberman MV, Becker C, Bedard MP. Congenital hepatic arteriovenous malformation: an unusual cause of neonatal persistent pulmonary hypertension. J Perinatol 2006; 26 (05) 316-318
• 98 Pfeifer J, Wohlgemuth WA, Abdul-Khaliq H. Liquid embolization of peripheral arteriovenous malformations with ethylene-vinyl alcohol copolymer in neonates and infants. Cardiovasc Ther 2022; 2022: 1022729
• 99 Chavan A, Caselitz M, Gratz KF. et al. Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations. Eur Radiol 2004; 14 (11) 2079-2085
• 100 Legiehn GM, Heran MKS. A step-by-step practical approach to imaging diagnosis and interventional radiologic therapy in vascular malformations. Semin Intervent Radiol 2010; 27 (02) 209-231
• 101 Cantasdemir M, Gulsen F, Solak S, Gulsen GY, Kantarci F, Numan F. The use of Onyx for embolization of peripheral vascular malformations in pediatric patients. Pediatr Surg Int 2012; 28 (05) 477-487
• 102 Zanjani KS, Mazloumi M, Zeinaloo A, Hedayati M, Khalilzadeh O, Yazdi HR. Transcatheter embolization of congenital hepatic arteriovenous malformation using ethylene-vinyl alcohol copolymer (Onyx). Diagn Interv Radiol 2012; 18 (02) 231-235
• 103 Bolus C, Yamada R, Alshora S, Hannegan C, Anderson B. Transarterial embolization of a hepatic arteriovenous malformation in an infant using Onyx: a case report and review of the differential diagnosis imaging findings. J Radiol Case Rep 2014; 8 (08) 33-42
• 104 Bernard O, Franchi-Abella S, Branchereau S, Pariente D, Gauthier F, Jacquemin E. Congenital portosystemic shunts in children: recognition, evaluation, and management. Semin Liver Dis 2012; 32 (04) 273-287
• 105 Sokollik C, Bandsma RHJ, Gana JC, van den Heuvel M, Ling SC. Congenital portosystemic shunt: characterization of a multisystem disease. J Pediatr Gastroenterol Nutr 2013; 56 (06) 675-681
• 106 Sakura N, Mizoguchi N, Eguchi T. et al. Elevated plasma bile acids in hypergalactosaemic neonates: a diagnostic clue to portosystemic shunts. Eur J Pediatr 1997; 156 (09) 716-718
• 107 Scalabre A, Gorincour G, Hery G, Gamerre M, Guys JM, de Lagausie P. Evolution of congenital malformations of the umbilical-portal-hepatic venous system. J Pediatr Surg 2012; 47 (08) 1490-1495
• 108 McLin VA, Franchi Abella S, Debray D. et al; Members of the International Registry of Congenital Porto-Systemic Shunts. Congenital portosystemic shunts: current diagnosis and management. J Pediatr Gastroenterol Nutr 2019; 68 (05) 615-622
• 109 Baiges A, Turon F, Simón-Talero M. et al; REHEVASC, VALDIG an EASL Consortium, Abernethy Group. Congenital extrahepatic portosystemic shunts (Abernethy malformation): an international observational study. Hepatology 2020; 71 (02) 658-669
• 110 Korff S, Mostaguir K, Beghetti M. et al. International registry of congenital porto-systemic shunts: a multi-centre, retrospective and prospective registry of neonates, children and adults with congenital porto-systemic shunts. Orphanet J Rare Dis 2022; 17 (01) 284
• 111 Abernethy J. Account of two instances of uncommon formation in the viscera of the human body: from the philosophical transactions of the Royal Society of London. Med Facts Obs 1797; 7: 100-108
• 112 Morgan G, Superina R. Congenital absence of the portal vein: two cases and a proposed classification system for portasystemic vascular anomalies. J Pediatr Surg 1994; 29 (09) 1239-1241
• 113 Lautz TB, Tantemsapya N, Rowell E, Superina RA. Management and classification of type II congenital portosystemic shunts. J Pediatr Surg 2011; 46 (02) 308-314
• 114 Rajeswaran S, Johnston A, Green J. et al. Abernethy malformations: evaluation and management of congenital portosystemic shunts. J Vasc Interv Radiol 2020; 31 (05) 788-794
• 115 Howard ER, Davenport M. Congenital extrahepatic portocaval shunts -- the Abernethy malformation. J Pediatr Surg 1997; 32 (03) 494-497
• 116 Stringer MD. The clinical anatomy of congenital portosystemic venous shunts. Clin Anat 2008; 21 (02) 147-157
• 117 Blanc T, Guerin F, Franchi-Abella S. et al. Congenital portosystemic shunts in children: a new anatomical classification correlated with surgical strategy. Ann Surg 2014; 260 (01) 188-198
• 118 Franchi-Abella S, Branchereau S, Lambert V. et al. Complications of congenital portosystemic shunts in children: therapeutic options and outcomes. J Pediatr Gastroenterol Nutr 2010; 51 (03) 322-330
• 119 Kanazawa H, Nosaka S, Miyazaki O. et al. The classification based on intrahepatic portal system for congenital portosystemic shunts. J Pediatr Surg 2015; 50 (04) 688-695
• 120 Franchi-Abella S, Gonzales E, Ackermann O, Branchereau S, Pariente D, Guérin F. International Registry of Congenital Portosystemic Shunt Members. Congenital portosystemic shunts: diagnosis and treatment. Abdom Radiol (NY) 2018; 43 (08) 2023-2036
• 121 Bahadori A, Kuhlmann B, Debray D. et al; On Behalf of the IRCPSS. Presentation of congenital portosystemic shunts in children. Children (Basel) 2022; 9 (02) 243